CH446367A - Verfahren zur Herstellung von neuen Lumilysergolderivaten - Google Patents

Verfahren zur Herstellung von neuen Lumilysergolderivaten

Info

Publication number
CH446367A
CH446367A CH723163A CH723163A CH446367A CH 446367 A CH446367 A CH 446367A CH 723163 A CH723163 A CH 723163A CH 723163 A CH723163 A CH 723163A CH 446367 A CH446367 A CH 446367A
Authority
CH
Switzerland
Prior art keywords
lumilysergole
derivatives
new
production
new lumilysergole
Prior art date
Application number
CH723163A
Other languages
English (en)
Inventor
Bernardi Luigi
Bosisio Germano
Goffredo Onofrio
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of CH446367A publication Critical patent/CH446367A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH723163A 1962-06-11 1963-06-10 Verfahren zur Herstellung von neuen Lumilysergolderivaten CH446367A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1167062 1962-06-11

Publications (1)

Publication Number Publication Date
CH446367A true CH446367A (de) 1967-11-15

Family

ID=11136772

Family Applications (1)

Application Number Title Priority Date Filing Date
CH723163A CH446367A (de) 1962-06-11 1963-06-10 Verfahren zur Herstellung von neuen Lumilysergolderivaten

Country Status (8)

Country Link
US (1) US3228943A (de)
AT (1) AT258481B (de)
BR (1) BR6349779D0 (de)
CH (1) CH446367A (de)
DK (1) DK103780C (de)
ES (1) ES288887A1 (de)
GB (1) GB981827A (de)
SE (1) SE315904B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
NL159384B (nl) * 1971-03-13 1979-02-15 Farmaceutici Italia Werkwijze voor het bereiden van een geneesmiddel met een adrenolytische activiteit, alsmede werkwijze voor het bereiden van een ester van 1-methyl-10-methoxylumilysergol.
GB1413068A (en) * 1972-06-22 1975-11-05 Farmaceutici Italia Bromoergolines
NL7400790A (de) * 1973-02-02 1974-08-06
US3996228A (en) * 1973-12-21 1976-12-07 Societa' Farmaceutici Italia S.P.A. Pyrimidinoaminoethyl ergoline derivatives
US3929796A (en) * 1974-08-02 1975-12-30 Lilly Co Eli Synthesis of penniclavine and elymoclavine
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
US4054567A (en) * 1975-08-11 1977-10-18 Eli Lilly And Company 6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds
US4082753A (en) * 1976-02-17 1978-04-04 Eli Lilly And Company Penniclavine acetonide
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
IT1173489B (it) * 1984-03-27 1987-06-24 Inverni Della Beffa Spa Procedimento di preparazione di 1-metil-10alfa-metossilumilisergolo e di suci esteri,e intermedi per la loro preparazione
IT1213206B (it) * 1984-08-07 1989-12-14 Inverni Della Beffa Spa Procedimento per la preparazione di derivati del lisergolo.
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2584720B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation de derives n-methyles de l'ergoline
FR2584719B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation des derives n-methyles du lysergol et du methoxy-10a lumilysergol
FR2584721B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation des derives n-methyles du dihydrolysergate de methyle ou du methoxylumilysergate de methyle
US4713385A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
US4683237A (en) * 1985-12-20 1987-07-28 Eli Lilly And Company Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
US5211504A (en) * 1991-01-31 1993-05-18 Roger Trudel Adjustable manhole top
FR2786100B1 (fr) 1998-11-24 2002-03-01 Aventis Laboratoire Nouvelle application therapeutique de la nicergoline
FR2786101B1 (fr) 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
JP3835763B2 (ja) 2002-08-19 2006-10-18 ファイザー・プロダクツ・インク 増殖亢進疾患のための組み合わせ治療
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
CA2909442A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP4470609A3 (de) 2019-01-18 2025-03-12 Astrazeneca AB Pcsk9-inhibitoren und verfahren zur verwendung davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155667A (en) * 1964-11-03 Process for the preparation of
GB786138A (en) * 1955-02-04 1957-11-13 Sandoz Ltd New ergot alkaloid derivatives and process of making same

Also Published As

Publication number Publication date
ES288887A1 (es) 1963-12-16
DE1470241A1 (de) 1969-12-11
SE315904B (de) 1969-10-13
BR6349779D0 (pt) 1973-07-03
GB981827A (en) 1965-01-27
US3228943A (en) 1966-01-11
AT258481B (de) 1967-11-27
DK103780C (da) 1966-02-21

Similar Documents

Publication Publication Date Title
CH446367A (de) Verfahren zur Herstellung von neuen Lumilysergolderivaten
AT261803B (de) Verfahren zur Herstellung von neuen Penicillinen
AT252890B (de) Verfahren zur Herstellung von neuen Hydroxydiaminen
AT261123B (de) Verfahren zur Herstellung von neuen Diacylcymarolen
AT242865B (de) Verfahren zur Herstellung von neuen Penicillinderivaten
AT239801B (de) Verfahren zur Herstellung von neuen Hydantoinderivaten
AT244479B (de) Verfahren zur Herstellung von neuen Farbstoffen
AT240865B (de) Verfahren zur Herstellung von neuen Thiaxanthen-Derivaten
AT272532B (de) Verfahren zur Herstellung von neuen Gonadienonen
AT254184B (de) Verfahren zur Herstellung von neuen Äthanoanthracenderivaten
AT242130B (de) Verfahren zur Herstellung von neuen Nitrofuryl-Derivaten
AT240849B (de) Verfahren zur Herstellung von neuen 5-Nitrofuran-Derivaten
AT243810B (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT242828B (de) Verfahren zur Herstellung von neuen Farbstoffen
CH431548A (de) Verfahren zur Herstellung von neuen Lumiergolinderivaten
AT255661B (de) Verfahren zur Herstellung von neuen 1-Cyancolchicinderivaten
AT242147B (de) Verfahren zur Herstellung von neuen 4-Hydroxy-5-halogen-pyrimidinderivaten
AT241474B (de) Verfahren zur Herstellung von neuen Trithiacyclopentanen
CH459218A (de) Verfahren zur Herstellung von neuen Phenthiazinamiden
AT248618B (de) Verfahren zur Herstellung von neuen Yohimbinderivaten
AT260428B (de) Verfahren zur Herstellung von neuen Yohimbanderivaten
CH440295A (de) Verfahren zur Herstellung von neuen Nitrofuran-Derivaten
AT248453B (de) Verfahren zur Herstellung von neuen Guanidinderivaten
AT239246B (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT243274B (de) Verfahren zur Herstellung von neuen Azepinderivaten